The T-carriers showed nominal significant number of MetS components (2.1 ± 1.4 versus 1.9 ± 1.4, P = 0.04), lower HDL (46.5 ± 11.3 versus 48.5 ± 11.0 mg/dL, P = 0.04), adiponectin (10.9 ± 6.2 versus 12.1 ± 7.2 ng/mL, P = 0.03), and increased number of MetS components and greater percentages of each MetS component were also noted in the T-carriers compared to those with the AA genotype (Table 2). This evidence concerns the gene ADIPOQ and metabolic syndrome.